FindTrial
Sign In

Remote Monitoring of patients having implantable cardiac devices.

Remote Monitoring Evaluation with cardiac implantable devices in India - CRM

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040509
Enrollment
788
Registered
2022-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified Health Condition 2: I258- Other forms of chronic ischemic heart disease

Interventions

None listed

Sponsors

Max Super Speciality Hospital A Unit of Devki Devi Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients implanted with marketed Abbott ICD/CRT/ devices

Exclusion criteria

Exclusion criteria: 1. Patients with life expectancy less than 12 months

Design outcomes

Primary

MeasureTime frame
The primary end point is to compare impact of remote monitoring on early detection of adverse events (death, stroke or cardiovascular events requiring surgical intervention or detection of Atrial fibrillation requiring medical intervention/Ablation) between the treatment and control arm. Timepoint: 24 months—

Secondary

MeasureTime frame
Descriptive end point of registry is to compare the impact of remote monitoring on reduction in number of ODP/Clinic and ER visitTimepoint: 24 months—

Countries

India

Contacts

Public ContactRajesh Saxena

Max Super Speciality Hospital

balbir.singh1@maxhealthcare.com09818474003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026